WORKWELL: Testing Work Advice for People With Arthritis (WORKWELL)

A Randomised Controlled Trial of Job Retention Vocational Rehabilitation for Employed People With Inflammatory Arthritis: the WORKWELL Trial.

Background: Inflammatory arthritis (IA) causes work disability, absenteeism (sick leave) and presenteeism (reduced productivity) at high cost to individuals, employers and society. A trial of job retention vocational rehabilitation (VR) amongst people with IA in the US showed that VR reduced work disability. However, it is unknown whether this approach transfers to the United Kingdom (UK) with a different social and welfare structure. Previously, we modified the VR for the UK, funded by Arthritis Research UK (the WORKWELL programme) and demonstrated it to be deliverable and acceptable in a feasibility trial. Our aim now is to move to the definitive UK trial testing the effectiveness and cost-effectiveness of WORKWELL.

Methods: A multicentre randomized controlled trial will be conducted. Employed people with rheumatoid, psoriatic or inflammatory arthritis (n=240), with concerns about continuing working due to arthritis, will be randomized to receive WORKWELL or control (written advice). WORKWELL includes individualised VR (maximum 4.5 hours over several months): assessing work problems; encouraging arthritis self-management in the workplace; addressing ergonomics; considering fatigue and stress management; providing orthoses and educating on employment rights and support services, assistive technology and work modifications. It also includes psychological and disclosure support, workplace visits and employer liaison (as applicable). Outcomes will be assessed at 0, 6 and 12 months by questionnaire. The primary outcome is the Work Limitations Questionnaire-25 (measuring presenteeism: summed score) at 12 and 36 months, with cost-effectiveness analysis at 12 months.

Discussion: If effective and cost-effective, WORKWELL can be rolled out in Rheumatology services to help improve the quality and duration of people with arthritis' working lives.

Study Overview

• Status: Active, not recruiting
• Conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic; Arthritis, Inflammatory
• Intervention / Treatment: Other: Control; Other: WORKWELL

Detailed Description

Background Work problems are common in people with inflammatory arthritis (IA). In rheumatoid arthritis (RA) 33% stop working within two years and 50% within 10 years. Work difficulties include: pain (particularly hand pain); fatigue; unadapted work environments, equipment and work schedules; poor work self-efficacy (i.e. lack of confidence about working); job strain; limited use of self-management strategies; and limited support from employers and work colleagues. Two USA trials of brief (3 hours) job retention vocational rehabilitation (VR) identified job loss was postponed by modifying such factors. A UK proof-of-principle trial (n=32) identified 10 hours (minimum) of VR reduced work instability. VR is not routinely available in the NHS and Rheumatology departments. It is unclear from the evidence if brief VR provided by therapists is effective and cost-effective in the UK.

Aims

1. Assess if there is a difference in work presenteeism between people with RA, undifferentiated IA (UIA) or psoriatic arthritis (PsA) who receive either: usual care, written work self-help information plus brief VR (WORKWELL) provided by a therapist trained in providing VR; or usual care and written work self-help information only (WP1).
2. To assess if there are differences in self-reported work instability, work, activity limitations, work productivity, absenteeism, work status, work self-efficacy, health status, NHS and societal costs between people receiving WORKWELL or written work self-help information only (WP1)
3. To assess the cost-effectiveness of WORKWELL from the perspective of: the NHS using health-related quality of life as the primary outcome; the employer using presenteeism as the primary outcome; and the employer using health-related quality of life as the primary outcome and including presenteeism as a cost. (WP5)
4. To update and evaluate a VR programme for occupational therapists and physiotherapists to help them keep people with RA, IA or PsA in work (WP2).
5. To measure fidelity to the WORKWELL intervention (WP3).
6. To understand the social and structural context in which the intervention is delivered and to identify factors which may influence the quality of implementation (WP3).
7. Investigate contextual factors influencing participants' presenteeism (WP4).

Design A pragmatic, multi-centre individually randomised controlled trial (RCT) comparing the effects of brief VR (intervention) with written self-help advice only (control). Cost-effectiveness and process evaluations will also be conducted.

Methodology Employed people with RA/ UIA/ PsA who have concerns about being able to continue to work in future due to arthritis, will be consented into the study. They will complete a baseline questionnaire (hard copy or online according to participant preference) and will then be randomly allocated in equal numbers, stratified by participants' job skill levels, to either intervention or control groups. Participants (in both groups) will be mailed a self-help work information pack. Participants' in the intervention group will be referred to receive the WORKWELL intervention from a trained occupational therapist/ physiotherapist. The Lancashire Clinical Trials Unit (CTU: University of Central Lancashire) will contact participants monthly by text/ e-mail/ telephone to identify numbers of days on sick leave. Six months after completing the baseline questionnaire, participants will complete a short postal/online questionnaire including presenteeism, productivity health status measures and resource data. At 12 months, participants will complete a third postal/online questionnaire with most of the measures collected at baseline. Two sub-samples from the intervention and control groups will be interviewed: employed participants about their views of VR; and any unemployed/ retired due to ill-health participants about factors contributing to job loss. At 36 months, participants will complete a fourth postal/online questionnaire with some of the key work status measures collected at baseline. Two sub-samples from the intervention and control groups will be interviewed: employed participants about their views of VR; and any unemployed/ retired due to ill-health participants about factors contributing to job loss.

Planned Sample Size 240 people will be recruited from 18 sites. On completion of the trial, qualitative interviews will be completed with 15 employed participants and up to 7 (if any) unemployed / early retired through ill-health from the intervention group. WORKWELL participants' line managers/employers will also be interviewed (where possible: n=10). WORKWELL Therapists and their line managers will also be interviewed (one each from each site, or less if data saturation is reached (n=18 for each).

Analyses Statistical analyses will investigate differences in outcomes at 12 and 36 months after baseline between intervention and control groups using mixed effects linear, logistic or ordinal logistic regression modelling, adjusted for baseline values and stratification variables (as applicable). The primary outcome is the summed score of the Combined Work Activities Limitations Scale -Work Limitations Questionnaire-25 (a measure of work presenteeism) at 12 and 36 months after baseline assessment. The health economic analysis will be conducted from the UK National Health Service (NHS) and employer perspectives. Interviews will be thematically analysed. Records will be analysed using content analysis.

• Study Type: Interventional
• Enrollment (Actual): 249
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Alison Hammond, PhD; Phone Number: 0161 295 0038; Email: a.hammond@salford.ac.uk
• Study Contact Backup: Name: Angela Ching, PhD; Phone Number: 0161 295 6979; Email: a.ching@salford.ac.uk

Study Locations

• United Kingdom
  • Avon
    • Bristol, Avon, United Kingdom, BS10 5NB
      • North Bristol NHS Trust
  • Cheshire
    • Chester, Cheshire, United Kingdom, CH2 1UL
      • Countess Of Chester Hospital NHS Foundation Trust
  • Co Tyne And Wear
    • Newcastle Upon Tyne, Co Tyne And Wear, United Kingdom, NE7 7DN
      • Newcastle Upon Tyne Hospitals NHS Trust.
  • Devon
    • Barnstaple, Devon, United Kingdom, EX31 4JB
      • Northern Devon Healthcare NHS Trust
  • Fife
    • Kirkcaldy, Fife, United Kingdom, KY1 2ND
      • NHS FIFE
  • Greater Manchester
    • Manchester, Greater Manchester, United Kingdom, M13 9WL
      • Manchester University NHS Foundation Trust
    • Salford, Greater Manchester, United Kingdom, M6 8HD
      • Salford Royal NHS Foundation Trust
  • Merseyside
    • St Helens, Merseyside, United Kingdom, WA9 3DA
      • St Helens and Knowsley Teaching Hospitals NHS Trust
  • Monmouthshire
    • Chepstow, Monmouthshire, United Kingdom, NP16 5YX
      • Aneurin Bevan University Health Board
  • Northumberland
    • Hexham, Northumberland, United Kingdom, NE46 1QJ
      • Northumbria Healthcare NHS Foundation Trust
  • Nottinghamshire
    • Sutton In Ashfield, Nottinghamshire, United Kingdom, NG17 4JL
      • Sherwood Forest Hospitals NHS Foundation Trust
  • Oxfordshire
    • Oxford, Oxfordshire, United Kingdom, OX3 7HE.
      • Oxford University Hospitals NHS Foundation Trust
  • Staffordshire
    • Cannock, Staffordshire, United Kingdom, WS11 5XY
      • The Royal Wolverhampton NHS Trust
  • Vale Of Glamorgan
    • Cardiff, Vale Of Glamorgan, United Kingdom, CF64 2XX
      • Cardiff and Vale UHB: LLandough Hospital
  • Wiltshire
    • Bath, Wiltshire, United Kingdom, BA1 1RL
      • Royal United Hospitals Bath NHS Foundation Trust
  • Worcestershire
    • Worcester, Worcestershire, United Kingdom, WR5 1DD
      • Worcestershire Acute Hospitals NHS Trust
  • Yorkshire
    • Barnsley, Yorkshire, United Kingdom, S75 2EP
      • Barnsley Hospitals NHS Foundation Trust
    • Leeds, Yorkshire, United Kingdom, LS7 4SA
      • The Leeds Teaching Hospitals Nhs Trust

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 68 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Adults (i.e. aged ≥ 18 years)
• diagnosed with RA, UIA or PsA by a Rheumatology Consultant. (Undifferentiated Inflammatory Arthritis is defined as: persistent synovitis in more than one small joint of the hand, without any other known cause, but the person does not yet meet all the diagnostic criteria for RA. Participants can have co-morbidities (which may also be related to having RA, UIA or PsA, for example, osteoarthritis, fibromyalgia, heart condition, mild to moderate anxiety or depression; or are unrelated, e.g. diabetes.
• In paid work (full or part-time, self-employed or contractual work) for at least 15 hours per week.
• Participants may be on sick leave at the time of screening BUT this must be for less than 4 weeks duration and not planned or likely to extend for longer than 4 weeks.
• Able to read and understand English.
• Score ≥10 on the RA-Work Instability Scale (RA-WIS), a measure of mismatch between the person's abilities and their job demands.
• Able to attend the participating site for WORKWELL appointments, if allocated to that group
• Able to provide informed consent.

Exclusion Criteria:

• on extended sick leave (i.e. > 4 weeks). The WORKWELL intervention is designed for people currently in work. Long-term sick leave is defined as being > 4 weeks [NICE, 2009b].
• Already planning to retire due to age or to take early retirement (for any health or non-health reason) within the next 12 months (i.e. within the trial follow-up period)
• planning to move out of area within the next 3 months and therefore would be unable to attend for WORKWELL sessions if allocated to that group (as treatment may not be completed in time).
• already receiving or awaiting VR services from Access to Work or a Vocational Rehabilitation company. These services conduct work assessments as part of VR provision. (Those receiving work services from other sources (e.g. occupational health or human resources in their organisation, online advice from Fit for Work) may still be recruited as VR provision can be of varied quality and this will be considered as "usual care."
• Employed in the armed forces (as they could be stationed overseas during the trial period. The armed services also have their own Vocational Rehabilitation service.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Control Group; The control group will receive a written work self-help information pack plus usual care. The pack includes published arthritis patient information booklets about work; a decision-tree flowchart; information about the UK Equality Act. The self-help information pack is mailed to the participants by the CTU following randomisation. Usual care consists of: prescribed medication; attending Rheumatology clinics; referral to rehabilitation, as and when deemed necessary from the Rheumatology clinic, but not including work advice. Any rehabilitation required will be provided as normal, e.g. provision of exercise, self-management education, activities of daily living advice, psychosocial support.	Other: Control; Published arthritis work booklets;written guidance on work problem identification; potential actions; Other Names: written work self-help information pack
Experimental: WORKWELL Group; The same as the Control Group (i.e. self-help information pack, plus usual care) PLUS the WORKWELL intervention. This consists of, on average, 4.5 hours contact, including: a structured work assessment; identification of work-related barriers and priority problems; collaborative treatment planning with the participant; a range of self-management, work advice and job modifications appropriate to the individual participant's problems; goal setting and action planning; and a 30 minute telephone review to identify progress with goals at the end of treatment.	Other: WORKWELL; Individualised, tailored work advice and work/vocational rehabilitation, including self-management and job modifications.; Other Names: Vocational rehabilitation; Work rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Combined Work Activities Limitations Scale - Work Limitations Questionnaire-25	Measure of presenteeism (i.e. productivity at work). Scale range 0-111Higher values indicate worse outcome	Change between 0 to 12 months; 0 to 36 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rheumatoid Arthritis Work Instability Scale	Measure of the degree of mismatch between functional abilities and workplace demands. Scale range 0-23. Higher scores indicate worse problems.	Change 0 to 12 months
Absenteeism	Number of days sick leave/month. Total number of sick days over 12 month period is calculated.	Monthly for 12 months
Work Self-Efficacy Scale	Confidence about working; 0-10 scale; higher scores indicate greater confidence	Change 0 to 12 months
Work Productivity and Activity Impairment Scale	Measures time off on sick leave or for any other reason, hours worked; health problems effect on work productivity and ability to do other daily activities; percentage absenteeism - all in the last 7 days. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity, i.e., worse outcomes, as follows: Scoring instructions available at: http://www.reillyassociates.net/WPAI_Scoring.html	Change 0 to 12 months
Short Form-12 (SF-12) Health Survey	Physical and mental health.	Change 0 to 12 months
EuroQol Five Dimensions QuestionnaireEQ5DL-5	Quality of Life Scale	Change 0 to 12 months.
Rheumatoid Arthritis Impact of Disease Scale	Domains of impact of RA: coping, helplessness, fatigue, physical function, sleep, global assessment and pain. RAID final value = (pain NRS value (range 0-10) x 0.21) + (function NRS value (range 0-10) x 0.16) + (fatigue NRS value (range 0-10) x 0.15) + (phys well being NRS value (range 010) x 0.12) + (sleep NRS value (range 0-10) x 0.12) + (emotional well being NRS value (range 0-10) x 0.12) + (coping NRS value (range 0-10) x 0.12). Thus, the range of the final RAID value is 0-10 where higher figures indicate worse status.	Change 0 to 12 months
RA Disease Activity Index-5	The RADAI contains five items on global disease activity during the past 6 months (item 1), current disease activity as measured by swollen and tender joints (item 2), current amount of arthritis pain (item 3), current duration of morning stiffness (item 4) and current number of tender joints in a joint list (item 5). The first three items are scored on an 11-point numerical rating scale, with verbal anchors from ''no disease activity''/''no pain'' (score 0) to ''extreme disease activity''/''extreme pain'' (score 10). The last two items are scored on a seven-point (item 4) and four-point (item 5) verbal rating scale.	Change 0 to 12 months
Health Resource Use Questionnaire	Measure of health resource use (secondary and primary care; social care; private health care)	cumulative health recourse use over 12 months
Work status	Options are whether in full- or part-time work; early retired; retired; unemployed	Change between 0 and 12 months; 0 to 36 months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Perceived Workplace Support Scale	Perceived level of managerial, co-worker and organisational support available to respondent. Each subscale is scored by adding the scores. Sub-scale a: managerial support score range 4 to 20; co-worker support scale b range 8-40; organisational support scale c score range 7-35. Higher scores indicate less support	Change 0 to 12 months
Work-Health - Personal Life Perceptions Scale: short form	Ability to balance demands of work, health and personal life. Score range 4 - 16, higher score indicates worse balance	Change 0 to 12 months
The Workplace Accommodations, Benefits, Policies and Practices Scale	a) The number of job accommodations, policies and workplace practices employees have available in their workplace (range 0 - 17), and b) how helpful they find it helpful each of these to manage health related work difficulties (1 to 5 scale). Higher scores indicate greater level of helpfulness	Change 0 to 12 months
The Work Transitions Index	Work disruptions due to arthritis	Change 0 to 12 months;

Collaborators and Investigators

• Sponsor: University of Salford
• Collaborators: University of Central Lancashire; Versus Arthritis; University of Manchester
• Investigators: Principal Investigator: Yeliz Prior, PhD, University of Salford; Principal Investigator: Alison Hammond, PhD, University of Salford

Publications and helpful links

General Publications

• Hammond A, Sutton C, Cotterill S, Woodbridge S, O'Brien R, Radford K, Forshaw D, Verstappen S, Jones C, Marsden A, Eden M, Prior Y, Culley J, Holland P, Walker-Bone K, Hough Y, O'Neill TW, Ching A, Parker J. The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial). BMC Musculoskelet Disord. 2020 Sep 10;21(1):607. doi: 10.1186/s12891-020-03619-1.
• Sutton C, Cotterill S, Forshaw D, Rhodes S, Haig A, Hammond A. SWAT 86 evaluation: Randomised evaluation of prenotification of trial participants before self-report outcome data collection to improve retention. Research Methods in Medicine and Health Sciences 2022 3(4): 107-115 https://doi.org/10.1177/26320843221098427
• Hammond A, Radford KA, Ching A, Prior Y, O'Brien R, Woodbridge S, Culley J, Parker J, Holland P. The Workwell trial: protocol for the process evaluation of a randomised controlled trial of job retention vocational rehabilitation for employed people with inflammatory arthritis. Trials. 2022 Nov 9;23(1):937. doi: 10.1186/s13063-022-06871-z.
• Ching A, Parker J, Haig A, Sutton CJ, Cotterill S, Forshaw D, Culley J, Hammond A. Job retention vocational rehabilitation for employed people with inflammatory arthritis: adaptations to the WORKWELL trial due to the impact of the COVID-19 pandemic. Trials. 2022 Dec 20;23(1):1030. doi: 10.1186/s13063-022-06941-2.

Study record dates

Study Major Dates

• Study Start (Actual): March 22, 2019
• Primary Completion (Estimated): March 30, 2024
• Study Completion (Estimated): December 31, 2024

Study Registration Dates

• First Submitted: September 8, 2018
• First Submitted That Met QC Criteria: May 6, 2019
• First Posted (Actual): May 8, 2019

Study Record Updates

• Last Update Posted (Estimated): December 21, 2023
• Last Update Submitted That Met QC Criteria: December 15, 2023
• Last Verified: December 1, 2023

More Information

Terms related to this study

• Keywords: rehabilitation; occupational therapy; presenteeism; employment; vocational rehabilitation; work rehabilitation
• Additional Relevant MeSH Terms: Skin Diseases; Immune System Diseases; Autoimmune Diseases; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin Diseases, Papulosquamous; Spinal Diseases; Bone Diseases; Spondylarthropathies; Spondylarthritis; Spondylitis; Psoriasis; Arthritis; Arthritis, Rheumatoid; Arthritis, Psoriatic
• Other Study ID Numbers: UoSWORKWELL1.1

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: UK Work Environment Survey (work assessment: already open access). Workwell Solutions Manual to be shared at end of trial (open access).
• IPD Sharing Time Frame: At end of trial.
• IPD Sharing Access Criteria: Application to study team
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF; CSR

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No